AbbVie Combo Doesn’t Benefit Covid Patients, Study Finds

(Bloomberg) -- A combination of antiviral drugs normally used to treat HIV didn’t benefit patients hospitalized for treatment of Covid-19, confirming earlier results that hadn’t been encouraging.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.